26 Years of Advancing EGFR-TKIs in Non-Small Cell Lung Cancer: Breakthroughs in Clinical Use and Resistance Mechanisms
Over the past three decades, the landscape of non-small cell lung cancer (NSCLC) treatment has been profoundly transformed by the ...
